J
John D. Martin
Researcher at University of Tokyo
Publications - 63
Citations - 10944
John D. Martin is an academic researcher from University of Tokyo. The author has contributed to research in topics: Tumor microenvironment & Medicine. The author has an hindex of 32, co-authored 52 publications receiving 8812 citations. Previous affiliations of John D. Martin include Massachusetts Institute of Technology & Harvard University.
Papers
More filters
Journal ArticleDOI
Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study.
Martha E. Shenton,Ron Kikinis,Ferenc A. Jolesz,Seth D. Pollak,Marjorie LeMay,Cynthia G. Wible,Hiroto Hokama,John D. Martin,Dave Metcalf,Michael J. Coleman,Robert W. McCarley +10 more
TL;DR: New MRI neuroimaging techniques are used to derive volume measurements and three-dimensional reconstructions of temporal-lobe structures in vivo in 15 right-handed men with chronic schizophrenia and 15 matched controls to discover the degree of thought disorder is related to the size of the reduction in volume of the left posterior superior temporal gyrus.
Journal ArticleDOI
Multistage nanoparticle delivery system for deep penetration into tumor tissue
Cliff Wong,Triantafyllos Stylianopoulos,Jian Cui,John D. Martin,Vikash P. Chauhan,Wen Jiang,Zoran B. Popović,Rakesh K. Jain,Moungi G. Bawendi,Dai Fukumura +9 more
TL;DR: In vivo circulationHalf-life and intratumoral diffusion measurements indicate that the multistage nanoparticles exhibited both the long circulation half-life necessary for the EPR effect and the deep tumor penetration required for delivery into the tumor's dense collagen matrix.
Journal ArticleDOI
Normalization of Tumour Blood Vessels Improves the Delivery of Nanomedicines in a Size-Dependent Manner
Vikash P. Chauhan,Triantafyllos Stylianopoulos,Triantafyllos Stylianopoulos,John D. Martin,John D. Martin,Zoran B. Popović,Ou Chen,Walid S. Kamoun,Moungi G. Bawendi,Dai Fukumura,Rakesh K. Jain +10 more
TL;DR: In this paper, the authors showed that repairing the abnormal vessels in mammary tumours, by blocking vascular endothelial growth factor receptor-2, improves the delivery of smaller nanoparticles (diameter, 12 nm) while hindering delivery of larger nanoparticles, and further suggest that smaller (∼12 nm) nanomedicines are ideal for cancer therapy due to their superior tumour penetration.
Journal ArticleDOI
Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
Yuhui Huang,Jianping Yuan,Elda Righi,Walid S. Kamoun,Marek Ancukiewicz,Jean Nezivar,Michael Santosuosso,John D. Martin,Margaret R. Martin,Fabrizio Vianello,Pierre Leblanc,Lance L. Munn,Peigen Huang,Dan G. Duda,Dai Fukumura,Rakesh K. Jain,Mark C. Poznansky +16 more
TL;DR: It is demonstrated that targeting tumor vasculature with lower vascular-normalizing doses, but not high antivascular/antiangiogenic doses, of an anti-VEGF receptor 2 (VEGFR2) antibody results in a more homogeneous distribution of functional tumor vessels.
Journal ArticleDOI
The role of mechanical forces in tumor growth and therapy.
TL;DR: Shear stresses exerted by flowing blood and interstitial fluid modulate the behavior of cancer and a variety of host cells, and taming these physical forces can improve therapeutic outcomes in many cancers.